The 2016 Irish America Healthcare and Life Sciences 50 list celebrates Irish innovators who are leading the way in diagnosis, treatment, and prevention of disease. The work of these Irish-American and Irish-born medical professionals contributes everyday to the health and wellness of our communities, from pharmaceuticals, medical devices and biotechnology to research and … [Read more...] about Healthcare and Life Sciences 50
Issues
First Word: Climb Every Mountain
When I was a kid my father would take us for drives to County Clare, or as he called it, “Biddy Early country.” We’d drive the back road, so narrow that the trees on either side reached across to each other, pass through the tiny village of Portroe, and stop at the top of a hill at a place called the Lookout to take in the view across Lough Derg to County Clare on the far … [Read more...] about First Word: Climb Every Mountain
Medical Breakthroughs that Matter
Irish universities are leading the way in breakthrough medical science. ℘℘℘ Testing Breakthroughs at QUB Queen’s University Belfast is leading the world’s first ever trial of a new combination of treatments for those with advanced prostate cancer. The trial, titled ADRRAD, recently began at the Northern Ireland Cancer Centre, and is funded by Friends of the Cancer Centre and … [Read more...] about Medical Breakthroughs that Matter
HIV on the Rise in Ireland
Recent figures from the Health Protection Surveillance Centre, Ireland’s specialist agency for the surveillance of communicable diseases, show a 30 percent increase in HIV cases in Ireland. To combat this, the Union of Students in Ireland teamed up with Operation Zero in June for Irish AIDS Days at nonprofit HIV Ireland, to spread their message: “no shame, no judgment, just … [Read more...] about HIV on the Rise in Ireland
New Cancer Drug May Skip Ireland
A groundbreaking new melanoma treatment is being rolled out to patients in the U.K., but may never reach those in Ireland. The National Pharmacoeconomics Centre (NCPE), an independent medicine cost advisory board, has recommended that the HSE does not make the Opdivo drug available through the public system due to uncertainty about its financial sustainability. Research has … [Read more...] about New Cancer Drug May Skip Ireland